Hanan S. Anbar

830 citations

45 papers · 605 indexed · h-index 16

Molecular Biology
Organic Chemistry top 10%
Oncology
Immunology
Computational Theory and Mathematics top 10%

Co-authors: Mohammed I. El–Gamal Mohammed I. El‐Gamal Seyed–Omar Zaraei Chang‐Hyun Oh Hamadeh Tarazi Sumera Zaib Jamshed Iqbal Jean Sévigny
Topics: Synthesis and biological activity (9 papers)Enzyme function and inhibition (7 papers)Melanoma and MAPK Pathways (6 papers)
Cited by: Physiology Organic Chemistry Molecular Biology
Journals: SHILAP Revista de lepidopterologíaPLoS ONE Molecules
Partner nations: Egypt United Arab Emirates South Korea

In The Last Decade

Hanan S. Anbar

44 papers receiving 597 citations

Peers

Countries citing papers authored by Hanan S. Anbar

Since Specialization

Citations

This map shows the geographic impact of Hanan S. Anbar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanan S. Anbar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanan S. Anbar more than expected).

Fields of papers citing papers by Hanan S. Anbar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanan S. Anbar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanan S. Anbar. The network helps show where Hanan S. Anbar may publish in the future.

Co-authorship network of co-authors of Hanan S. Anbar

This figure shows the co-authorship network connecting the top 25 collaborators of Hanan S. Anbar. A scholar is included among the top collaborators of Hanan S. Anbar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanan S. Anbar. Hanan S. Anbar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Synthesis, in vitro and in vivo evaluation, and computational modeling analysis of thioxothiazolidine derivatives as highly potent and selective α-amylase inhibitors 2025 ·European Journal of Medicinal Chemistry ·(unknown),(unknown),(unknown),(unknown),Hafiz Saqib Ali,Mohammed I. El‐Gamal,Hanan S. Anbar	0
2	Protective potential of Irosustat, STX140 and the sulfonate derivative 1G in counteracting cisplatin-induced renal and hepatic toxicities: An in vivo comparative study 2025 ·Life Sciences ·Hanan S. Anbar,Abd‐Elgawad Radi,(unknown),(unknown),(unknown),(unknown),(unknown),Mohammed I. El–Gamal,Wolfgang Döhle,Barry V. L. Potter,Hany A. Omar,(unknown)	1
3	The wound healing and hypoglycemic activates of date palm (Phoenix dactylifera) leaf extract and saponins in diabetic and normal rats 2024 ·PLoS ONE ·Hanan S. Anbar,Naglaa Gamil Shehab,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Aliasgar Shahiwala	2
4	Evaluation of regression of diabetes-induced nephropathy and vascular dysfunction in rats by Montelukast via antioxidative and anti-inflammatory actions 2023 ·Journal of Applied Pharmaceutical Science ·Hanan S. Anbar,George S.G. Shehatou,Mona Abdel Rahim,Ghada M. Suddеk,Nariman M. Gameil	2
5	Over-the-counter antibiotic dispensing: knowledge and practice of community pharmacists in the United Arab Emirates 2023 ·Journal of Pharmaceutical Health Services Research ·(unknown),(unknown),Ammar Abdulrahman Jairoun,Hanan S. Anbar	2
6	Promising drug candidates for the treatment of polycystic ovary syndrome (PCOS) as alternatives to the classical medication metformin 2023 ·European Journal of Pharmacology ·Hanan S. Anbar,(unknown),(unknown),(unknown),Tamanna Islam,Fatema Hersi,Hany A. Omar,Wolfgang Döhle,Barry V. L. Potter,Mohammed I. El‐Gamal	6
7	Novel Anti-Acanthamoebic Activities of Irosustat and STX140 and Their Nanoformulations 2023 ·Antibiotics ·Ruqaiyyah Siddiqui,Mutasem Rawas‐Qalaji,Mohammed I. El–Gamal,(unknown),(unknown),Seyed–Omar Zaraei,(unknown),Hanan S. Anbar,Wolfgang Döhle,Barry V. L. Potter,Naveed Ahmed Khan	5
8	Design and synthesis of new adamantyl derivatives as promising antiproliferative agents 2022 ·European Journal of Medicinal Chemistry ·(unknown),Seyed–Omar Zaraei,(unknown),Saif Ullah,Hanan S. Anbar,(unknown),Varsha Menon,Mohammed S. Abdel‐Maksoud,Chang‐Hyun Oh,Raafat El‐Awady,Nicolly Espíndola Gelsleichter,Julie Pelletier,Jean Sévigny,Jamshed Iqbal,Taleb H. Al‐Tel,Mohammed I. El‐Gamal	7
9	Design and synthesis of new quinoline derivatives as selective C-RAF kinase inhibitors with potent anticancer activity 2022 ·European Journal of Medicinal Chemistry ·Seyed–Omar Zaraei,(unknown),Hanan S. Anbar,(unknown),Hamadeh Tarazi,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Raafat El‐Awady,Taleb H. Al‐Tel,Mohammed I. El‐Gamal	18
10	Design, synthesis, and biological evaluation of a new series of pyrazole derivatives: Discovery of potent and selective JNK3 kinase inhibitors 2022 ·Bioorganic & Medicinal Chemistry ·(unknown),Anusha Sebastian,Vunnam Srinivasulu,(unknown),Hamadeh Tarazi,Hanan S. Anbar,(unknown),Seyed–Omar Zaraei,Sara M. Elgendy,(unknown),Hany A. Omar,Taleb H. Al‐Tel,Mohammed I. El–Gamal	9
11	A Review of HER4 (ErbB4) Kinase, Its Impact on Cancer, and Its Inhibitors 2021 ·Molecules ·Mohammed I. El–Gamal,(unknown),(unknown),(unknown),Hamadeh Tarazi,(unknown),(unknown),Seyed–Omar Zaraei,(unknown),Hanan S. Anbar	38
12	Discovery of urease inhibitory effect of sulfamate derivatives: Biological and computational studies 2021 ·Bioorganic Chemistry ·Sumera Zaib,(unknown),Seyed–Omar Zaraei,Imtiaz Khan,Hanan S. Anbar,Mohammed I. El‐Gamal	15
13	Current status and future prospects of p38α/MAPK14 kinase and its inhibitors 2021 ·European Journal of Medicinal Chemistry ·(unknown),Hanan S. Anbar,Mohammed I. El–Gamal	78
14	Discovery of first-in-class imidazothiazole-based potent and selective ErbB4 (HER4) kinase inhibitors 2021 ·European Journal of Medicinal Chemistry ·Seyed–Omar Zaraei,(unknown),(unknown),Hanan S. Anbar,(unknown),Hamadeh Tarazi,(unknown),Mohammed S. Abdel‐Maksoud,Chang‐Hyun Oh,Mohammed I. El–Gamal	21
15	A new series of aryl sulfamate derivatives: Design, synthesis, and biological evaluation 2020 ·Bioorganic & Medicinal Chemistry ·Mohammed I. El‐Gamal,Seyed–Omar Zaraei,Paul Foster,Hanan S. Anbar,(unknown),Raafat El‐Awady,Barry V. L. Potter	16
16	Sulfonate and sulfamate derivatives possessing benzofuran or benzothiophene nucleus as potent carbonic anhydrase II/IX/XII inhibitors 2019 ·Bioorganic & Medicinal Chemistry ·Seyed–Omar Zaraei,Mohammed I. El‐Gamal,Zainab Shafique,(unknown),Saifullah Afridi,Sumera Zaib,Hanan S. Anbar,(unknown),Jamshed Iqbal	12
17	Sulfamates in drug design and discovery: Pre-clinical and clinical investigations 2019 ·European Journal of Medicinal Chemistry ·Seyed–Omar Zaraei,Abduelmula R. Abduelkarem,Hanan S. Anbar,(unknown),(unknown),(unknown),Mohammed I. El‐Gamal	26
18	Synthesis, biological evaluation, and docking studies of new raloxifene sulfonate or sulfamate derivatives as inhibitors of nucleotide pyrophosphatase/phosphodiesterase 2019 ·European Journal of Medicinal Chemistry ·Mohammed I. El–Gamal,Saif Ullah,Seyed–Omar Zaraei,(unknown),Sumera Zaib,Dana M. Zaher,Hany A. Omar,Hanan S. Anbar,Julie Pelletier,Jean Sévigny,Jamshed Iqbal	25
19	Synthesis, biological evaluation, and molecular docking study of sulfonate derivatives as nucleotide pyrophosphatase/phosphodiesterase (NPP) inhibitors 2019 ·Bioorganic & Medicinal Chemistry ·Mohammad H. Semreen,Mohammed I. El‐Gamal,Saif Ullah,(unknown),Sumera Zaib,Hanan S. Anbar,(unknown),Jean Sévigny,Jamshed Iqbal	16
20	Comparison of the effects of levocetirizine and losartan on diabetic nephropathy and vascular dysfunction in streptozotocin-induced diabetic rats 2016 ·European Journal of Pharmacology ·Hanan S. Anbar,George S.G. Shehatou,Ghada M. Suddеk,Nariman M. Gameil	22

About Hanan S. Anbar

Hanan S. Anbar is a scholar working on Physiology, Organic Chemistry and Applied Microbiology and Biotechnology, having authored 45 papers that have together received 605 indexed citations. Recurring topics across this work include Synthesis and biological activity (9 papers), Enzyme function and inhibition (7 papers) and Melanoma and MAPK Pathways (6 papers). The work is most often cited by research in Physiology (43 citations), Organic Chemistry (224 citations) and Molecular Biology (272 citations). Hanan S. Anbar has collaborated with scholars based in Egypt, United Arab Emirates and South Korea. Frequent co-authors include Mohammed I. El–Gamal, Mohammed I. El‐Gamal, Seyed–Omar Zaraei, Chang‐Hyun Oh, Hamadeh Tarazi, Sumera Zaib, Jamshed Iqbal, Jean Sévigny, Saif Ullah and Kyung Ho Yoo. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Molecules.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact